Detalhe da pesquisa
1.
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 21(6): 1523-1532.e1, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421583
2.
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals.
Liver Int
; 43(7): 1593-1603, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035867
3.
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
Liver Int
; 43(8): 1761-1771, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088979
4.
Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction.
Int J Mol Sci
; 24(8)2023 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108628
5.
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
J Hepatol
; 77(3): 596-606, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405176
6.
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series.
Liver Int
; 42(4): 864-870, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132767
7.
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.
J Hepatol
; 74(4): 775-782, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248170
8.
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors.
Transfusion
; 61(12): 3381-3389, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647620
9.
Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19.
Blood
; 136(6): 766-768, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559762
10.
Reply to: "Polygenic risk score: A promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease".
J Hepatol
; 74(6): 1494-1496, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676949
11.
Genetic insight into COVID-19-related liver injury.
Liver Int
; 41(1): 227-229, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098230
12.
MAFLD vs NAFLD: Let the contest begin!
Liver Int
; 40(9): 2079-2081, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32930521
13.
Predictors of controlled attenuation parameter in metabolic dysfunction.
United European Gastroenterol J
; 12(3): 364-373, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141028
14.
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids.
Cell Rep Med
; 5(1): 101352, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232700
15.
Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases.
Front Genet
; 14: 1137016, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37388930
16.
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction.
Aliment Pharmacol Ther
; 57(10): 1093-1102, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947711
17.
Liver Involvement in Patients with Rare MBOAT7 Variants and Intellectual Disability: A Case Report and Literature Review.
Genes (Basel)
; 14(8)2023 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37628684
18.
The Long Non-Coding BC200 Is a Novel Circulating Biomarker of Parathyroid Carcinoma.
Front Endocrinol (Lausanne)
; 13: 869006, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35586620
19.
Clinical and genetic determinants of the fatty liver-coagulation balance interplay in individuals with metabolic dysfunction.
JHEP Rep
; 4(12): 100598, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313186
20.
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study.
Hepatol Commun
; 6(4): 867-877, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811949